For decades, the pharmaceutical industry has grappled with the inherent inefficiencies of drug discovery, a process often likened to searching…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A significant paradigm shift is underway in the pharmaceutical industry’s approach to small-molecule drug discovery, as a new collaborative platform,…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A new collaborative platform, ADME-One, has been launched by Ginkgo Datapoints, Tangible Scientific, and Inductive Bio, signaling a significant shift…
Read More
Ginkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&D
The landscape of biopharmaceutical research and development (R&D) is undergoing a seismic shift, driven by the integration of advanced robotics…
Read More
The Autonomous Revolution: How Ginkgo Bioworks is Driving a Paradigm Shift in Biopharma R&D
The biopharmaceutical industry, long reliant on the meticulous, hands-on work of human researchers, is on the cusp of a profound…
Read More
Ginkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&D
The biopharmaceutical industry is on the cusp of a profound transformation, driven by the burgeoning integration of artificial intelligence (AI)…
Read More
